UK markets open in 2 hours 15 minutes
NIKKEI 225
39,065.81 +448.71 (+1.16%) HANG SENG
18,930.02 -265.58 (-1.38%) CRUDE OIL
77.05 -0.52 (-0.67%) GOLD FUTURES
2,374.80 -18.10 (-0.76%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,615.52 +75.02 (+0.14%)
scPharmaceuticals Inc. (SCPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 127.63M |
| Enterprise value | 109.99M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.79 |
| Price/book (mrq) | 5.20 |
| Enterprise value/revenue | 6.24 |
| Enterprise value/EBITDA | -6.69 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.09 |
| 52-week change 3 | -65.53% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 11.7500 |
| 52-week low 3 | 3.4600 |
| 50-day moving average 3 | 4.7922 |
| 200-day moving average 3 | 5.8111 |
Share statistics
| Avg vol (3-month) 3 | 233.06k |
| Avg vol (10-day) 3 | 346.41k |
| Shares outstanding 5 | 36.05M |
| Implied shares outstanding 6 | 38.96M |
| Float 8 | 16.19M |
| % held by insiders 1 | 11.65% |
| % held by institutions 1 | 73.30% |
| Shares short (30 Apr 2024) 4 | 4.84M |
| Short ratio (30 Apr 2024) 4 | 28.18 |
| Short % of float (30 Apr 2024) 4 | 15.98% |
| Short % of shares outstanding (30 Apr 2024) 4 | 13.43% |
| Shares short (prior month 28 Mar 2024) 4 | 4.62M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -259.85% |
Management effectiveness
| Return on assets (ttm) | -36.26% |
| Return on equity (ttm) | -114.99% |
Income statement
| Revenue (ttm) | 17.63M |
| Revenue per share (ttm) | 0.45 |
| Quarterly revenue growth (yoy) | 195.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -59.67M |
| Net income avi to common (ttm) | -57.71M |
| Diluted EPS (ttm) | -1.3700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 58.98M |
| Total cash per share (mrq) | 1.64 |
| Total debt (mrq) | 40.8M |
| Total debt/equity (mrq) | 166.09% |
| Current ratio (mrq) | 6.21 |
| Book value per share (mrq) | 0.68 |
Cash flow statement
| Operating cash flow (ttm) | -60.45M |
| Levered free cash flow (ttm) | -40.04M |
© 2024 Yahoo. All rights reserved.